For more than a decade, scientists have tested a group of cancer drugs known as BET inhibitors with high hopes. The science behind them seemed strong. Many tumors rely on oncogenes that are switched on with help from “Bromo- and Extra-Terminal…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply